Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Association between MTHFR gene polymorphisms and the risk of autism spectrum disorders: a meta-analysis.

Pu D, Shen Y, Wu J.

Autism Res. 2013 Oct;6(5):384-92. doi: 10.1002/aur.1300. Epub 2013 May 7.

PMID:
23653228
2.
3.

Association of methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: a systematic review and meta-analysis update.

Fu LY, Dai LM, Li XG, Zhang K, Bai Y.

Eur J Obstet Gynecol Reprod Biol. 2014 Jan;172:56-61. doi: 10.1016/j.ejogrb.2013.10.001. Epub 2013 Oct 10. Review.

PMID:
24192663
4.

Methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and susceptibility to Parkinson's disease: a meta-analysis.

Wu YL, Ding XX, Sun YH, Yang HY, Sun L.

J Neurol Sci. 2013 Dec 15;335(1-2):14-21. doi: 10.1016/j.jns.2013.09.006. Epub 2013 Sep 12. Review.

PMID:
24064257
5.

Meta-analysis of MTHFR C677T and A1298C gene polymorphisms: association with the risk of hepatocellular carcinoma.

Qi YH, Yao LP, Cui GB, Liang J, Shao QJ, Yan LF, Du P.

Clin Res Hepatol Gastroenterol. 2014 Apr;38(2):172-80. doi: 10.1016/j.clinre.2013.10.002. Epub 2013 Dec 6. Review.

PMID:
24316043
6.

Association between methylenetetrahydrofolate reductase (MTHFR) C677T/A1298C polymorphisms and essential hypertension: a systematic review and meta-analysis.

Wu YL, Hu CY, Lu SS, Gong FF, Feng F, Qian ZZ, Ding XX, Yang HY, Sun YH.

Metabolism. 2014 Dec;63(12):1503-11. Review.

PMID:
25458833
7.

Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility.

Xia LZ, Liu Y, Xu XZ, Jiang PC, Ma G, Bu XF, Zhang YJ, Yu F, Xu KS, Li H.

World J Gastroenterol. 2014 Aug 28;20(32):11429-38. doi: 10.3748/wjg.v20.i32.11429. Review.

8.

A meta-analysis of MTHFR C677T and A1298C polymorphisms and risk of acute lymphoblastic leukemia in children.

Yan J, Yin M, Dreyer ZE, Scheurer ME, Kamdar K, Wei Q, Okcu MF.

Pediatr Blood Cancer. 2012 Apr;58(4):513-8. doi: 10.1002/pbc.23137. Epub 2011 Apr 14. Review.

PMID:
21495160
9.

Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis.

Khandanpour N, Willis G, Meyer FJ, Armon MP, Loke YK, Wright AJ, Finglas PM, Jennings BA.

J Vasc Surg. 2009 Mar;49(3):711-8. doi: 10.1016/j.jvs.2008.10.004. Epub 2009 Jan 21. Review.

10.

Methylenetetrahydrofolate reductase gene polymorphisms and recurrent pregnancy loss in China: a systematic review and meta-analysis.

Chen H, Yang X, Lu M.

Arch Gynecol Obstet. 2016 Feb;293(2):283-90. doi: 10.1007/s00404-015-3894-8. Epub 2015 Sep 23. Review.

PMID:
26399758
11.

Association between MTHFR C677T polymorphism and diabetic nephropathy in the Chinese population: An updated meta-analysis and review.

Xiong X, Lin XK, Xiao X, Qin DP, Zhou DY, Hu JG, Liu Y, Zhong XS.

Nephrology (Carlton). 2016 Jan;21(1):5-12. doi: 10.1111/nep.12541. Review.

PMID:
26072975
12.

5,10-Methylenetetrahydrofolate reductase polymorphisms and acute lymphoblastic leukemia risk: a meta-analysis.

Pereira TV, Rudnicki M, Pereira AC, Pombo-de-Oliveira MS, Franco RF.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1956-63. Review.

13.
14.

Cervical cancer with polymorphism in MTHFR C677T gene: a systematic review and meta-analysis.

Xu XJ, Zou LW, Wang DB.

Mol Biol Rep. 2013 Jan;40(1):255-62. doi: 10.1007/s11033-012-2056-3. Epub 2012 Oct 16. Review.

PMID:
23070908
15.

Meta-analysis of MTHFR gene variants in schizophrenia, bipolar disorder and unipolar depressive disorder: evidence for a common genetic vulnerability?

Peerbooms OL, van Os J, Drukker M, Kenis G, Hoogveld L; MTHFR in Psychiatry Group, de Hert M, Delespaul P, van Winkel R, Rutten BP.

Brain Behav Immun. 2011 Nov;25(8):1530-43. doi: 10.1016/j.bbi.2010.12.006. Epub 2010 Dec 24. Review.

PMID:
21185933
16.

Methylenetetrahydrofolate Reductase A1298C Polymorphism and Breast Cancer Risk: A Meta-analysis of 33 Studies.

Rai V.

Ann Med Health Sci Res. 2014 Nov;4(6):841-51. doi: 10.4103/2141-9248.144873. Review.

17.

Assessing the association between the methylenetetrahydrofolate reductase (MTHFR) 677C>T polymorphism and blood folate concentrations: a systematic review and meta-analysis of trials and observational studies.

Tsang BL, Devine OJ, Cordero AM, Marchetta CM, Mulinare J, Mersereau P, Guo J, Qi YP, Berry RJ, Rosenthal J, Crider KS, Hamner HC.

Am J Clin Nutr. 2015 Jun;101(6):1286-94. doi: 10.3945/ajcn.114.099994. Epub 2015 Mar 18. Review.

18.

Relationship between methylenetetrahydrofolate reductase (MTHFR) A1298C gene polymorphism and type 2 diabetic nephropathy risk: a meta-analysis.

Zhang J, Xiao Y, Zhang XW, Gao ZQ, Han JH.

Ren Fail. 2014 Jul;36(6):974-8. doi: 10.3109/0886022X.2014.900426. Epub 2014 Mar 31. Review.

PMID:
24678913
19.

MTHFR C677T and A1298C polymorphisms were associated with bladder cancer risk and disease progression: a meta-analysis.

You W, Li Z, Jing C, Qian-Wei X, Yu-Ping Z, Weng-Guang L, Hua-Lei L.

DNA Cell Biol. 2013 May;32(5):260-7. doi: 10.1089/dna.2012.1931. Epub 2013 Apr 11. Review.

PMID:
23578207
20.

Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.

Lee YH, Song GG.

Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:8-14. doi: 10.1016/j.ejogrb.2013.12.030. Epub 2014 Jan 3. Review.

PMID:
24439532

Supplemental Content

Support Center